Health – Moderna seeks approval of RSV vaccine for the elderly – Health
Cambridge/Munich (dpa) – The American company Moderna intends to apply for approval of an RSV vaccine for adults over the age of 60 in the first half of the year. The vaccine called “mRNA-1345” has shown “promising results” in the phase 3 study required for approval, the company announced on Tuesday evening. Respiratory syncytial virus … Read more